Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers
by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o
Updated on: January 29,2024
18
Potent results from a new immune treatment seen in patients with hard-to-treat blood cancers
by Peter MacCallum Cancer CentreCredit: Pixabay/CC0 Public DomainAll patients in the Phase I / II clinical trial of glofitamab had Diffuse Large B-Cell Lymphoma (DLBCL) and their cancer had relapsed o
Updated on:January 29,2024
18
